Supercharged antibiotics could turn tide against superbugs

January 5, 2018, University of Queensland
Supercharged antibiotics could turn tide against superbugs
Dr Mark Blaskovich. The number of patients dying from vancomycin-resistant bacteria prompted his team to look at revitalising old antibiotics. Credit: University of Queensland

An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world's most dangerous superbugs.

The supercharge technique , led by Dr. Mark Blaskovich and Professor Matt Cooper from UQ's Institute for Molecular Bioscience (IMB), potentially could revitalise other .

Antibiotic-resistant bacteria – superbugs – cause 700,000 deaths worldwide each year, and a UK government review has predicted this could rise to 10 million by 2050.

Dr. Blaskovich said the old drug, vancomycin, was still widely used to treat extremely dangerous bacterial infections, but bacteria were becoming increasingly resistant to it.

"The rise of vancomycin-resistant bacteria, and the number of patients dying from resistant infections that cannot be successfully treated, stimulated our team to look at ways to revitalise old antibiotics," Dr. Blaskovich said.

"We did this by modifying vancomycin's membrane-binding properties to selectively bind to bacterial membranes rather than those of human cells, creating a series of supercharged vancomycin derivatives called vancapticins."

The rebooted vancomycin has the potential to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Professor Cooper said pharmaceutical companies had departed the antibiotic discovery field because new antibiotics were difficult to find and were not as lucrative as cholesterol-lowering medications or cancer treatments.

"Hence many scientists are re-engineering existing drugs to overcome bacterial resistance, rather than searching for new drugs," he said.

"Drug development is normally focused on improving binding to a biological target, and rarely focuses on assessing membrane-binding properties.

"This approach worked with the vancapticins, and the question now is whether it can be used to revitalise other antibiotics that have lost effectiveness against resistant bacteria.

"Given the alarming rise of multi-drug resistant and the length of time it takes to develop a new antibiotic, we need to look at any solution that could fix the antibiotic discovery pipeline now," Professor Cooper said.

Explore further: Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells

More information: Mark A. T. Blaskovich et al. Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria, Nature Communications (2017). DOI: 10.1038/s41467-017-02123-w

Related Stories

Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells

February 3, 2017
Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.

Understanding drug-resistant superbugs

July 18, 2016
News reports reveal drug-resistant super bacteria identified as carbapenem-resistant Enterobacteriaceae (CRE) have been found in the waters of Rio de Janeiro where the 2016 Olympics sailing events will be held.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.